Pulse.

a daily field guide to health research that matters

◆ Console

‹ Fri · 6 Nov 2026
Standard addition

The effect of subcutaneous semaglutide injection on blood pressure: a systematic review and meta-analysis of randomized controlled trials.

Semaglutide consistently lowers blood pressure alongside weight loss, adding cardiovascular benefit for people with obesity.

A meta-analysis pooled seven randomized trials evaluating blood-pressure effects of subcutaneous semaglutide. The consistent systolic reduction strengthens cardiometabolic benefit evidence, while the smaller diastolic effect was less robust.

What the study was

Study design
Systematic review and meta-analysis of randomized controlled trials
Population
Participants receiving subcutaneous semaglutide in seven randomized trials
Sample size
20000
Category
Prevention
Maturity
Validated
Journal
Diabetes research and clinical practice

Why it surfaced

Large randomized evidence provides a reliable cardiometabolic effect estimate, although the outcome is intermediate rather than a clinical event.

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.